Brenntag, DE000A1DAHH0

Brenntag SE stock (DE000A1DAHH0): Global leader in chemical distribution

14.05.2026 - 10:59:41 | ad-hoc-news.de

Brenntag SE, the world's largest chemical distributor, connects chemical manufacturers with end-users across industries. The company reported steady growth in its latest annual results, with strong performance in North America.

Brenntag, DE000A1DAHH0
Brenntag, DE000A1DAHH0

Brenntag SE, a leading global distributor of chemicals and ingredients, continues to serve diverse industries including pharmaceuticals, food, personal care and industrial manufacturing. The company operates in over 70 countries, providing value-added services like blending, packaging and logistics. Recent financials highlight resilience amid supply chain challenges, with Q4 2025 results showing stable EBITDA margins according to Brenntag IR as of 03/2026.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

  • Name: Brenntag SE
  • Sector/industry: Specialty chemicals distribution
  • Headquarters/country: Essen, Germany
  • Core markets: North America, EMEA, Asia Pacific, Latin America
  • Key revenue drivers: Industrial chemicals, specialties, logistics services
  • Home exchange/listing venue: Frankfurt Stock Exchange (Xetra)
  • Trading currency: EUR

Official source

For first-hand information on Brenntag SE, visit the company’s official website.

Go to the official website

Brenntag SE: core business model

Brenntag SE acts as an essential link in the chemical value chain, sourcing products from manufacturers and delivering them to over 190,000 customers worldwide. Its business model emphasizes local expertise with global reach, operating through regional hubs that tailor solutions to specific market needs. The company generated €16.8 billion in revenue for fiscal year 2024 (published March 2025), per Brenntag annual report as of 03/2025.

Key to its operations are value-added services such as just-in-time delivery, custom blending and technical support, which differentiate Brenntag from pure commodity traders. The specialties segment, focusing on high-margin ingredients for pharma and nutrition, now accounts for about 35% of group sales, up from prior years.

Main revenue and product drivers for Brenntag SE

Brenntag's revenue is split between industrial chemicals (65%) and specialties (35%), with North America contributing 37% of total sales in 2024. Major drivers include essential chemicals for water treatment, coatings and adhesives, alongside growth in life science ingredients. The company benefits from long-term supplier contracts and a vast product portfolio exceeding 1 million SKUs.

Logistics optimization and digital tools like the myBrenntag platform enhance efficiency, supporting margin expansion. In 2024, EBITDA reached €1.2 billion, reflecting 7.1% margins for the full year ending December 31, 2024 (reported March 2025).

Industry trends and competitive position

The chemical distribution sector is projected to grow at 4-5% CAGR through 2030, driven by sustainability demands and supply chain localization, according to S&P Global as of 01/2025. Brenntag holds a leading 10-15% global market share, ahead of competitors like Univar Solutions and Azelis.

Its scale enables investments in green chemistry distribution and circular economy solutions, positioning it well for regulatory shifts like REACH in Europe and TSCA compliance in the US.

Why Brenntag SE matters for US investors

Brenntag's North American division, the largest regionally, generates over one-third of group revenue and serves key US industries like personal care and food processing. US investors gain exposure to resilient chemical demand tied to manufacturing recovery and pharma growth. The stock trades as an ADR on US platforms, offering easy access.

Main revenue and product drivers for Brenntag SE

In the US, Brenntag focuses on specialties for nutrition and pharma, capitalizing on domestic production trends post-COVID. Recent acquisitions have bolstered its footprint in high-growth segments like biopharma ingredients.

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Conclusion

Brenntag SE maintains a strong position in chemical distribution with diversified revenue streams and operational efficiency. Recent results underscore stability in core markets, while strategic focus on specialties supports long-term growth. Investors track upcoming quarterly releases for margin trends amid economic shifts.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.

So schätzen die Börsenprofis Brenntag Aktien ein!

<b>So schätzen die Börsenprofis  Brenntag Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | DE000A1DAHH0 | BRENNTAG | boerse | 69331691 | bgmi